<DOC>
	<DOCNO>NCT01082380</DOCNO>
	<brief_summary>The rationale study investigate absorption , metabolism excretion [ 14C ] PF 02341066 characterize plasma , fecal urinary radioactivity , identify metabolite , possible , [ 14C ] PF 02341066 human .</brief_summary>
	<brief_title>Radiolabeled 14CPF-02341066 Study To Investigate The Absorption , Metabolism And Excretion In Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Crizotinib</mesh_term>
	<criteria>Healthy male subject age 18 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 17.5 30.5 kg/m^2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>radiolabeled</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>